Related Experiment Video
Updated: Sep 29, 2025

Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Predictors for insulin use in gestational diabetes mellitus
Heather Louise Ford1, Isabella Champion2, Anna Wan3
1Monash Health, Department of Obstetrics and Gynaecology, Melbourne, Australia; Monash University, Department of Obstetrics and Gynaecology, Melbourne, Australia.
Predictors like elevated OGTT results, high birth weight history, previous GDM, South Asian region birth, BMI, and age can help identify women with gestational diabetes mellitus (GDM) needing insulin therapy. This aids in early counselling for expecting mothers.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Gestational diabetes mellitus (GDM) affects 15% of pregnancies in Australia, with 30% requiring insulin.
- Predicting insulin needs in GDM is crucial for timely intervention.
- Limited research exists on predicting insulin therapy requirements based on GDM risk factors.
Purpose of the Study:
- To identify predictors of insulin therapy in women diagnosed with GDM.
- To establish a predictive model for insulin use in pregnant women with GDM.
Main Methods:
- Retrospective cohort study of 2,048 women with GDM (2016-2017) in Melbourne, Australia.
- Data collected from hospital records and pathology results.
- Univariable and multivariable logistic regression models used to identify predictors.
Main Results:
- Elevated fasting OGTT, previous birth weight >90th%, prior GDM diagnosis, South Asian region birth, 2hr OGTT result, BMI, and age predicted insulin use.
- The final predictive model achieved an AUC of 0.744.
- 31.6% of women with GDM required insulin therapy.
Conclusions:
- Identified key predictors for insulin therapy in GDM.
- Findings can inform counselling for newly diagnosed GDM patients.
- Highlights the utility of OGTT results and patient history in predicting insulin needs.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors

